Location London, England, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type
LinkedIn View on LinkedIn
Sam joined in 2007 and is engaged in Apposite's Healthcare Services investments. He has been involved in deal-making in the healthcare sector since 2000 when he joined Deutsche Bank's mergers and acquisitions practice, working with a number of multinational clients on corporate divestitures and acquisitions, including public takeovers and
leveraged buy-outs. Sam then joined the Business Development team at Belgian pharmaceutical company, UCB, where he worked on global product licensing and M&A, including UCB's $2.7bn acquisition of the UK public biotech company, Celltech. Sam has a first degree in Natural Sciences and a masters degree in Chemistry from Cambridge University, as well as an MBA from Harvard Business School.
